1-3 of 3
Hans-Henning Flechtner
Close
Sort by
Journal Articles

Longitudinal Evaluation of Quality of Life and Fatigue In Hodgkin Lymphoma Patients

Peter Borchmann, MD, Horst Müller, Corinne Brillant, Karolin Behringer, Teresa Halbsguth, MD, Volker Diehl, Hans Henning Flechtner, Andreas Engert, MD
Journal: Blood
Blood (2010) 116 (21): 935.
https://doi.org/10.1182/blood.V116.21.935.935
Published: 2010
Journal Articles

“Quality of Life (QoL) in the Randomised HD10-12 Trials of the German Hodgkin Study Group (GHSG): Sexual Functions (SX) in Hodgkin Lymphoma (HL) Patients Decrease by Disease Stage and Improve After Therapy Depending On Stage and Treatment Modality.”.

Karolin Behringer, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Teresa Halbsguth, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, MD, Peter Borchmann
Journal: Blood
Blood (2009) 114 (22): 896.
https://doi.org/10.1182/blood.V114.22.896.896
Published: 2009
Journal Articles

Quality of Life in a 2-Year Follow-up: Signs of PNP Predicting Cognitive Functioning in Survivors Treated in the HD10–12 Trials of the German Hodgkin Study Group (GHSG).

Teresa Halbsguth, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Karolin Behringer, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2008) 112 (11): 1455.
https://doi.org/10.1182/blood.V112.11.1455.1455
Published: 2008